Pfizer SEC filings: 8-K

Filter: All · 8-K · 10-Q · 10-K · Form 4

8-KNov. 3, 2026, 8:07 a.m. ETView on SEC.gov Our explainer
Results of operations and financial condition · Financial statements and exhibits
AI summary, unreviewedPfizer Q3 2026 adjusted EPS of $0.87 beats $0.73 consensus on $16.6 billion revenue; full-year adjusted EPS guidance raised to $2.95-$3.05
8-KAug. 4, 2026, 7:02 a.m. ETView on SEC.gov
Results of operations and financial condition · Financial statements and exhibits